| PROPOSED O3 CONCENTRATIONS (mcg/ml per ml of blood) | ||
|---|---|---|
| Initial | Final | |
| Infectious diseases | 20–25 | 70 |
| Vascular diseases | 20 | 40–50 |
| Degenerative diseases | 20 | 30–40 |
| Respiratory diseases | 10 | 30–40 |
| Autoimmune diseases | 20–40 | 80 |
| Metastatic tumours | 25 | 70–90 |
| PROPOSED O3 CONCENTRATIONS (mcg/ml per ml of blood) | ||
|---|---|---|
| Initial | Final | |
| Infectious diseases | 20–25 | 70 |
| Vascular diseases | 20 | 40–50 |
| Degenerative diseases | 20 | 30–40 |
| Respiratory diseases | 10 | 30–40 |
| Autoimmune diseases | 20–40 | 80 |
| Metastatic tumours | 25 | 70–90 |